Short-term outcomes of combined therapy with sirolimus and interferon-alpha 2b for advanced hepatic epithelioid hemangioendothelioma.
Xiaolei LiuRuiquan ZhouLiguo LiuShuang SiShiwei YangDongdong HanHaidong TanPublished in: Therapeutic advances in medical oncology (2024)
Sirolimus and IFN-a 2b may have synergistic effects in the treatment of hepatic EHE. SI therapy is a safe and effective treatment for hepatic EHE patients with good ECOG performance status.